Caplyta 21 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FQ70T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,561
Award facts
- Contract value 100% obligated
- $1,561.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Caplyta 21 mg capsules (30-count units) with a ceiling value of $1,561.30. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract is valued at up to $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications and medical supplies to support military healthcare programs worldwide. The ultimate completion date for this delivery order is September 12, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Caplyta is an atypical antipsychotic medication used to treat psychiatric conditions including schizophrenia and bipolar disorder. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, demonstrates significant capability in federal medical procurement through its extensive portfolio of brand-name and generic medications supplied across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other military and veteran healthcare systems. This delivery order represents one of numerous small-value pharmaceutical transactions fulfilled under the company's prime vendor relationship with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB25FQ70T?
SPE2DB25FQ70T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FQ70T worth?
The government has obligated $1,561 on SPE2DB25FQ70T.
Is contract SPE2DB25FQ70T an order under another contract?
Yes. SPE2DB25FQ70T is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ70T competed?
The extent of competition for SPE2DB25FQ70T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award